As a leading independent diagnostic laboratory, LabCorp participates in a highly attractive duopoly that offers bright prospects as healthcare moves toward reformed payment models, despite current ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
The US Food and Drug Administration (FDA) on Tuesday granted an emergency use authorization (EUA) to LabCorp allowing it to test self-collected nasal swab samples from patients for coronavirus disease ...
The FDA has granted emergency approval use for a coronavirus test that can be conducted by patients at their homes. The FDA re-issued emergency use approval for the Pixel by LabCorp COVID-19 home ...
BURLINGTON, N.C. (WJZY) — North Carolina-based LabCorp announced Tuesday that it has received an Emergency Use Authorization from the U.S. Food and Drug Administration for at-home COVID-19 test kits.
(Reuters) - LabCorp said on Thursday it has launched a new test that could assess the capacity of antibodies in patient plasma to inhibit the novel coronavirus. Information from the test about the ...
Home self-test kits to detect COVID-19 offer convenience and fast results. Several players in the market promote their own versions. For example, with a prescription and $25, BinaxNOW provides their ...
State health officials announced they were reducing the official count of completed COVID-19 tests Wednesday by more than 200,000 after discovering a "discrepancy" in data provided by one of the ...
LabCorp posted full-year results that ran ahead of our expectations on the top and bottom lines for 2021. However, that outperformance was offset after adjusting our 2022 projections downward as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results